Mycobacterium Citations List: September, 2016

Literature Citations

1. Identification of KasA as the Cellular Target of an Anti-tubercular Scaffold. Abrahams, K.A., C.W. Chung, S. Ghidelli-Disse, J. Rullas, M.J. Rebollo-Lopez, S.S. Gurcha, J.A. Cox, A. Mendoza, E. Jimenez-Navarro, M.S. Martinez-Martinez, M. Neu, A. Shillings, P. Homes, A. Argyrou, R. Casanueva, N.J. Loman, P.J. Moynihan, J. Lelievre, C. Selenski, M. Axtman, L. Kremer, M. Bantscheff, I. Angulo-Barturen, M.C. Izquierdo, N.C. Cammack, G. Drewes, L. Ballell, D. Barros, G.S. Besra, and R.H. Bates. Nature Communications, 2016. 7(12581): 13pp. PMID[27581223]. PMCID[PMC5025758].
[PubMed]. TB_09_2016.

2. Anti-mycobacterial Activity of Thymine Derivatives Bearing Boron Clusters. Adamska, A., A. Rumijowska-Galewicz, A. Ruszczynska, M. Studzinska, A. Jabionska, E. Paradowska, E. Bulska, H. Munier-Lehmann, J. Dziadek, Z.J. Lesnikowski, and A.B. Olejniczak. European Journal of Medicinal Chemistry, 2016. 121: p. 71-81. PMID[27236064].
[PubMed]. TB_09_2016.

3. Synthesis, Antimicrobial and Antitubercular Activities of Some Novel Pyrazoline Derivatives. Ahmad, A., A. Husain, S.A. Khan, M. Mujeeb, and A. Bhandari. Journal of Saudi Chemical Society, 2016. 20(5): p. 577-584. ISI[000382295100013].
[WOS]. TB_09_2016.

4. Total Synthesis of (+/-)-Isoperbergins and Correction of the Chemical Structure of Perbergin. Almabruk, K.H., J.H. Chang, and T. Mahmud. Journal of Natural Products, 2016. 79(9): p. 2391-2396. PMID[27588436].
[PubMed]. TB_09_2016.

5. Mono- and Polynuclear Ferrocenylthiosemicarbazones: Synthesis, Characterisation and Antimicrobial Evaluation. Baartzes, N., T. Stringer, J. Okombo, R. Seldon, D.F. Warner, C. de Kock, P.J. Smith, and G.S. Smith. Journal of Organometallic Chemistry, 2016. 819: p. 166-172. ISI[000382199000021].
[WOS]. TB_09_2016.

6. Spirooxindoles as Novel 3D-Fragment Scaffolds: Synthesis and Screening against CYP121 from M. tuberculosis. Davis, H.J., M.E. Kavanagh, T. Balan, C. Abell, and A.G. Coyne. Bioorganic & Medicinal Chemistry Letters, 2016. 26(15): p. 3735-3740. PMID[27287372 ].
[PubMed]. TB_09_2016.

7. Discovery of in Vitro Antitubercular Agents through in Silico Ligand-based Approaches. De Vita, D., F. Pandolfi, R. Cirilli, L. Scipione, R. Di Santo, L. Friggeri, M. Mori, D. Fiorucci, G. Maccari, R.S.A. Christopher, C. Zamperini, V. Pau, A. De Logu, S. Tortorella, and M. Botta. European Journal of Medicinal Chemistry, 2016. 121: p. 169-180. PMID[27240272].
[PubMed]. TB_09_2016.

8. Micrococcin P1 - a Bactericidal Thiopeptide Active against Mycobacterium tuberculosis. Degiacomi, G., Y. Personne, G. Mondesert, X. Ge, C.S. Mandava, R.C. Hartkoorn, F. Boldrin, P. Goel, K. Peisker, A. Benjak, M.B. Barrio, M. Ventura, A.C. Brown, V. Leblanc, A. Bauer, S. Sanyal, S.T. Cole, S. Lagrange, T. Parish, and R. Manganelli. Tuberculosis, 2016. 100: p. 95-101. PMID[27553416].
[PubMed]. TB_09_2016.

9. Synthesis and Antimicrobial Evaluation of 1-[(2-Substituted phenyl)carbamoyl]naphthalen-2-yl Carbamates. Gonec, T., S. Pospisilova, L. Holanova, J. Stranik, A. Cernikova, V. Pudelkova, J. Kos, M. Oravec, P. Kollar, A. Cizek, and J. Jampilek. Molecules, 2016. 21(9): 1189. PMID[27617988].
[PubMed]. TB_09_2016.

10. Antibacterial and Anticancer Activity of a Series of Novel Peptides Incorporating Cyclic Tetra-substituted C(alpha) Amino acids. Hicks, R.P. Bioorganic Medicinal Chemistry, 2016. 24(18): p. 4056-4065. PMID[27387357].
[PubMed]. TB_09_2016.

11. Asymmetric Total Synthesis of (-)-Erogorgiaene and Its C-11 Epimer and Investigation of Their Antimycobacterial Activity. Incerti-Pradillos, C.A., M.A. Kabeshov, P.S. O'Hora, S.A. Shipilovskikh, A.E. Rubtsov, V.A. Drobkova, S.Y. Balandina, and A.V. Malkov. Chemistry, 2016. 22(40): p. 14390-14396. PMID[27529822].
[PubMed]. TB_09_2016.

12. Development of Potent Chemical Antituberculosis Agents Targeting Mycobacterium tuberculosis Acetohydroxyacid Synthase. Jung, I.P., N.R. Ha, S.C. Lee, S.W. Ryoo, and M.Y. Yoon. International Journal of Antimicrobial Agents, 2016. 48(3): p. 247-258. PMID[27451857].
[PubMed]. TB_09_2016.

13. Substrate Fragmentation for the Design of M. tuberculosis CYP121 Inhibitors. Kavanagh, M.E., J.L. Gray, S.H. Gilbert, A.G. Coyne, K.J. McLean, H.J. Davis, A.W. Munro, and C. Abell. ChemMedChem, 2016. 11(17): p. 1924-1935. PMID[27432475].
[PubMed]. TB_09_2016.

14. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic acid Transporter, MmpL3. Li, W., A. Obregon-Henao, J.B. Wallach, E.J. North, R.E. Lee, M. Gonzalez-Juarrero, D. Schnappinger, and M. Jackson. Antimicrobial Agents and Chemotherapy, 2016. 60(9): p. 5198-5207. PMID[27297488].
[PubMed]. TB_09_2016.

15. The Structure-antimicrobial Activity Relationships of a Promising Class of the Compounds Containing the N-Arylpiperazine Scaffold. Malik, I., J. Csollei, J. Jampilek, L. Stanzel, I. Zadrazilova, J. Hosek, S. Pospisilova, A. Cizek, A. Coffey, and J. O'Mahony. Molecules, 2016. 21(10): 1274. PMID[27681720].
[PubMed]. TB_09_2016.

16. Isolation of alpha-Linolenic acid from Sutherlandia frutescens and Its Inhibition of Mycobacterium tuberculosis' Shikimate Kinase Enzyme. Masoko, P., I.H. Mabusa, and R.L. Howard. BMC Complementary Alternative Medicine, 2016. 16(366): 8pp. PMID[27639973]. PMCID[PMC5027073].
[PubMed]. TB_09_2016.

17. Arrival of Imidazo[2,1‑b]thiazole-5-carboxamides: Potent Antituberculosis Agents That Target QcrB.Moraski, G.C., N. Seeger, P.A. Miller, A.G. Oliver, H.I. Boshoff, S. Cho, S. Mulugeta, J.R. Anderson, S.G. Franzblau, and M.J. Miller. ACS Infectious Diseases, 2016. 2(6): p. 393-398.

TB_09_2016.

18. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium. Nikonenko, B.V., A. Kornienko, K. Majorov, P. Ivanov, T. Kondratieva, M. Korotetskaya, A.S. Apt, E. Salina, and V. Velezheva. Antimicrobial Agents and Chemotherapy, 2016. 60(10): p. 6422-6424. PMID[27503657].
[PubMed]. TB_09_2016.

19. Isoniazid Minimal Inhibitory Concentrations of Tuberculosis Strains with katG Mutation. Otto-Knapp, R., S. Vesenbeckh, N. Schonfeld, G. Bettermann, A. Roth, T. Bauer, H. Russmann, and H. Mauch. International Journal of Tuberculosis and Lung Disease, 2016. 20(9): p. 1275-1276. PMID[27510258].
[PubMed]. TB_09_2016.

20. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase. Palencia, A., X. Li, W. Bu, W. Choi, C.Z. Ding, E.E. Easom, L. Feng, V. Hernandez, P. Houston, L. Liu, M. Meewan, M. Mohan, F.L. Rock, H. Sexton, S. Zhang, Y. Zhou, B. Wan, Y. Wang, S.G. Franzblau, L. Woolhiser, V. Gruppo, A.J. Lenaerts, T. O'Malley, T. Parish, C.B. Cooper, M.G. Waters, Z. Ma, T.R. Ioerger, J.C. Sacchettini, J. Rullas, I. Angulo-Barturen, E. Perez-Herran, A. Mendoza, D. Barros, S. Cusack, J.J. Plattner, and M.R. Alley. Antimicrobial Agents Chemotherapy, 2016. 60(10): p. 6271-6280. PMID[27503647].
[PubMed]. TB_09_2016.

21. Effects of Lipid-lowering Drugs on Vancomycin Susceptibility of Mycobacteria. Rens, C., F. Laval, M. Daffe, O. Denis, R. Frita, A. Baulard, R. Wattiez, P. Lefevre, and V. Fontaine. Antimicrobial Agents and Chemotherapy, 2016. 60(10): p. 6193-6199. PMID[27503643].
[PubMed]. TB_09_2016.

22. Design and Development of New Class of Mycobacterium tuberculosisl-alanine Dehydrogenase Inhibitors. Reshma, R.S., S. Saxena, K.A. Bobesh, V.U. Jeankumar, S. Gunda, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry, 2016. 24(18): p. 4499-4508. PMID[27477207].
[PubMed]. TB_09_2016.

23. A Convenient Synthesis and Screening of Benzosuberone Bearing 1,2,3-Triazoles against Mycobacterium tuberculosis. Sajja, Y., S. Vanguru, L. Jilla, H.R. Vulupala, R. Bantu, P. Yogeswari, D. Sriram, and L. Nagarapu. Bioorganic & Medicinal Chemistry Letters, 2016. 26(17): p. 4292-4295. PMID[27476139].
[PubMed]. TB_09_2016.

24. Synthesis and in Vitro Study of Some Fused 1,2,4-Triazole Derivatives as Antimycobacterial Agents. Seelam, N., S.P. Shrivastava, S. Prasanthi, and S. Gupta. Journal of Saudi Chemical Society, 2016. 20(4): p. 411-418. ISI[000381709100007].
[WOS]. TB_09_2016.

25. Bis-Biguanide dihydrochloride Inhibits Intracellular Replication of M. tuberculosis and Controls Infection in Mice. Shen, H., F. Wang, G. Zeng, L. Shen, H. Cheng, D. Huang, R. Wang, L. Rong, and Z.W. Chen. Scientific Reports, 2016. 6(32725): 10pp. PMID[27601302]. PMCID[PMC5013693].
[PubMed]. TB_09_2016.

26. Antimicrobial Peptides as Novel Anti-tuberculosis Therapeutics. Silva, J.P., R. Appelberg, and F.M. Gama. Biotechnology Advances, 2016. 34(5): p. 924-940. PMID[27235189].
[PubMed]. TB_09_2016.

27. Bortezomib Inhibits Bacterial and Fungal Beta-carbonic Anhydrases. Supuran, C.T. Bioorganic & Medicinal Chemistry, 2016. 24(18): p. 4406-4409. PMID[27469982].
[PubMed]. TB_09_2016.

28. Inhibition of Bacterial RNase P RNA by Phenothiazine Derivatives. Wu, S., G. Mao, and L.A. Kirsebom. Biomolecules, 2016. 6(38): 16pp. PMID[27618117].
[PubMed]. TB_09_2016.

29. A Subset of Protective gamma9delta2 T Cells Is Activated by Novel Mycobacterial Glycolipid Components. Xia, M., D.C. Hesser, P. De, I.G. Sakala, C.T. Spencer, J.S. Kirkwood, G. Abate, D. Chatterjee, K.M. Dobos, and D.F. Hoft. Infection and Immunity, 2016. 84(9): p. 2449-2462. PMID[27297390]. PMCID[PMC4995917].
[PubMed]. TB_09_2016.

30. DC-159a Shows Inhibitory Activity against DNA Gyrases of Mycobacterium leprae. Yamaguchi, T., K. Yokoyama, C. Nakajima, and Y. Suzuki. Plos Neglected Tropical Diseases, 2016. 10(9): p. e0005013. PMID[27681932].
[PubMed]. TB_09_2016.

31. In Vitro Antimicrobial Activities of Animal-used Quinoxaline 1,4-di-N-Oxides against Mycobacteria, Mycoplasma and Fungi. Zhao, Y., G. Cheng, H. Hao, Y. Pan, Z. Liu, M. Dai, and Z. Yuan. BMC Veterinary Research, 2016. 12(186): 13pp. PMID[27600955]. PMCID[PMC5011961].
[PubMed]. TB_09_2016.